{
  "docId": "019de073-e60e-740c-a4d1-b8dd6fcd421d",
  "docSlug": "c76f9a1cfbf11e27618f62d901587aa3",
  "documentTitle": "Alkermes | Results Presentation Deck | 22 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 22,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 11,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-e60e-740c-a4d1-b8dd6fcd421d/16",
  "deckHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d",
  "deckJsonHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d.json",
  "deckAnchorHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.57,
        "x": 0.065,
        "y": 0.255
      },
      "kind": "chart",
      "text": "ARISTADA Quarterly TRx MOT",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d00865a0-bba7-476a-91e0-4e6912173fe6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.28,
        "x": 0.67,
        "y": 0.265
      },
      "kind": "list",
      "text": "Q3'22 year-over-year growth of 7% on TRx months of therapy (MOT) basis\nMarket share:\nTRx MOT: 10% of atypical LAI market prescriptions in Q3'22",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8095e251-e9ca-46ac-9302-2ba362c00d6e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.08,
        "x": 0.056,
        "y": 0.895
      },
      "kind": "source-note",
      "text": "Source: IQVIA NPA",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd709e2c-d125-44b1-8f35-418ae9d8e119",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.415,
        "x": 0.056,
        "y": 0.125
      },
      "kind": "title",
      "text": "ARISTADA® Prescription Growth Trends",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ad6ef1e0-089f-4d35-a0d1-bc3a2a156ea2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 22,
      "from": 10,
      "beatId": "15481a88-7d9b-424a-8a52-79b16c99f649",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The document provides a roadmap for next steps and presents financial results and operational performance to encourage action.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}